Phospho-MET (Tyr1234/1235) Rabbit PE Conjugate

<strong>Phospho-MET(Tyr1234/1235) Rabbit PE Conjugate </strong>_x000D_ <strong>Catalog number:</strong> B2018879_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 10 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> 155.54 kDa_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> 2-8℃_x000D_ <strong>Keywords:</strong> AUTS9; c-Met; Hepatocyte growth factor receptor; HGF receptor; HGF/SF receptor; HGFR; MET; met proto-oncogene (hepatocyte growth factor receptor); met proto-oncogene tyrosine kinase; oncogene MET; Proto-oncogene c-Met; RCCP2; Scatter factor receptor; SF receptor; Tyrosine-protein kinase Met_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Lim L, Wu CC, Hsu YT, Sun FJ, Chang CL. Clinical significance of c-Met and phospho-c-Met (Tyr1234/1235) in ovarian cancer Taiwan J Obstet Gynecol. 2019 Jan;58(1):105-110._x000D_ 2: Tsuta K, Kozu Y, Mimae T, Yoshida A, Kohno T, Sekine I, Tamura T, Asamura H, Furuta K, Tsuda H. c-MET/phospho-MET protein expression and MET gene copy number in non-small cell lung carcinomas J Thorac Oncol. 2012 Feb;7(2):331-9._x000D_ 3: Moores SL, Chiu ML, Bushey BS, Chevalier K, Luistro L, Dorn K, Brezski RJ, Haytko P, Kelly T, Wu SJ, Martin PL, Neijssen J, Parren PW, Schuurman J, Attar RM, Laquerre S, Lorenzi MV, Anderson GM. A Novel Bispecific Antibody Targeting EGFR and cMet Is Effective against EGFR Inhibitor-Resistant Lung Tumors Cancer Res. 2016 Jul 1;76(13):3942-53._x000D_ 4: Ramesh S, Cifci A, Javeri S, Minne RL, Longhurst CA, Nickel KP, Kimple RJ, Baschnagel AM. MET Inhibitor Capmatinib Radiosensitizes MET Exon 14-Mutated and MET-Amplified Non-Small Cell Lung Cancer Int J Radiat Oncol Biol Phys. 2024 Apr 1;118(5):1379-1390._x000D_ 5: Ramesh S, Cifci A, Javeri S, Minne R, Longhurst CA, Nickel KP, Kimple RJ, Baschnagel AM. MET Inhibitor Capmatinib Radiosensitizes MET Exon 14-Mutated and MET-Amplified Non-Small Cell Lung Cancer bioRxiv [Preprint]. 2023 Oct 27:2023.10.26.564232._x000D_ 6: Sun W, Ai T, Gao Y, Zhang Y, Cui J, Song L. Expression and prognostic relevance of MET and phospho-BAD in non-small cell lung cancer Onco Targets Ther. 2013 Sep 18;6:1315-23._x000D_ 7: Haratake N, Ozawa H, Morimoto Y, Yamashita N, Daimon T, Bhattacharya A, Wang K, Nakashoji A, Isozaki H, Shimokawa M, Kikutake C, Suyama M, Hashinokuchi A, Takada K, Takenaka T, Yoshizumi T, Mitsudomi T, Hata AN, Kufe D. MUC1-C Is a Common Driver of Acquired Osimertinib Resistance in NSCLC J Thorac Oncol. 2024 Mar;19(3):434-450._x000D_ 8: Organ SL, Tong J, Taylor P, St-Germain JR, Navab R, Moran MF, Tsao MS. Quantitative phospho-proteomic profiling of hepatocyte growth factor (HGF)-MET signaling in colorectal cancer J Proteome Res. 2011 Jul 1;10(7):3200-11._x000D_ 9: Roper N, El Meskini R, Maity T, Atkinson D, Day A, Pate N, Cultraro CM, Pack S, Zgonc V, Weaver Ohler Z, Guha U. Functional Heterogeneity in MET Pathway Activation in PDX Models of Osimertinib-resistant EGFR-driven Lung Cancer Cancer Res Commun. 2024 Feb 8;4(2):337-348._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/38386085">10: Redmer T, Schumann E, Peters K, Weidemeier ME, Nowak S, Schroeder HWS, Vidal A, Radbruch H, Lehmann A, Kreuzer-Redmer S, Jürchott K, Radke J. MET receptor serves as a promising target in melanoma brain metastases Acta Neuropathol. 2024 Feb 22;147(1):44. </a>_x000D_ _x000D_ <strong>Products Related to Phospho-MET(Tyr1234/1235) Rabbit PE Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>